KZR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Kezar Life Sciences Insider Trading History Chart

Kezar Life Sciences Share Price & Price History

^$0.79

▼ -0.03 (-3.67%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Now Open: Crypto emergency update

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Kezar Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/6/2023	Morningside Venture Investment	Major Shareholder	Sell	40,000	$6.88	$275,200.00	5,447,993
2/3/2023	Morningside Venture Investment	Major Shareholder	Sell	25,000	$7.15	$178,750.00	5,487,993
1/30/2023	Morningside Venture Investment	Major Shareholder	Sell	30,000	$6.91	$207,300.00	5,632,993
1/25/2023	Morningside Venture Investment	Major Shareholder	Sell	50,000	$6.85	$342,500.00	5,662,993
1/23/2023	Morningside Venture Investment	Major Shareholder	Sell	80,000	$6.81	$544,800.00	5,792,993
1/17/2023	Morningside Venture Investment	Major Shareholder	Sell	6,114	$6.79	$41,514.06	5,872,993
1/12/2023	Morningside Venture Investment	Major Shareholder	Sell	5,000	$6.77	$33,850.00	5,881,078
1/5/2023	Morningside Venture Investment	Major Shareholder	Sell	12,162	$6.97	$84,769.14	5,889,078
10/3/2022	Morningside Venture Investment	Major Shareholder	Sell	28,700	$8.78	$251,986.00	6,080,352
3/21/2022	Franklin M Berger	Director	Buy	20,000	$14.77	$295,400.00
3/18/2022	Franklin M Berger	Director	Buy	60,000	$16.74	$1,004,400.00
1/3/2022	Michael Kauffman	Director	Sell	5,000	$16.45	$82,250.00

Now Open: Crypto emergency update

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SEC Filings (Institutional Ownership Changes) for Kezar Life Sciences (NASDAQ:KZR)

67.90% of Kezar Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kezar Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	3,063,484	$2.90M	0.0%	+0.8%	4.214%
3/1/2024	Goldman Sachs Group Inc.	442,721	$0.42M	0.0%	-68.0%	0.609%
2/16/2024	GSA Capital Partners LLP	260,407	$0.25M	0.0%	N/A	0.358%
2/15/2024	Barclays PLC	98,037	$93K	0.0%	+678.6%	0.135%
2/15/2024	Vanguard Group Inc.	3,063,484	$2.90M	0.0%	+0.8%	4.214%
2/15/2024	Granahan Investment Management LLC	1,906,175	$1.81M	0.1%	+31.2%	2.622%
2/15/2024	Bridgeway Capital Management LLC	158,600	$0.15M	0.0%	-48.9%	0.218%
2/14/2024	Avidity Partners Management LP	5,025,454	$4.76M	0.2%	-16.4%	6.914%
2/14/2024	Schroder Investment Management Group	350,394	$0.33M	0.0%	N/A	0.482%
2/13/2024	Northern Trust Corp	543,466	$0.52M	0.0%	-4.6%	0.748%
2/13/2024	Goldman Sachs Group Inc.	442,721	$0.42M	0.0%	-68.0%	0.609%
2/8/2024	Panagora Asset Management Inc.	84,087	$80K	0.0%	N/A	0.116%
2/7/2024	BNP Paribas Financial Markets	201,887	$0.19M	0.0%	+140.9%	0.278%
2/6/2024	Charles Schwab Investment Management Inc.	226,490	$0.22M	0.0%	-34.4%	0.312%
1/12/2024	SG Americas Securities LLC	43,950	$42K	0.0%	+33.8%	0.060%
11/21/2023	Walleye Capital LLC	376,580	$0.45M	0.0%	-12.3%	0.518%
11/17/2023	Jacobs Levy Equity Management Inc.	308,576	$0.37M	0.0%	-48.8%	0.425%
11/14/2023	Avidity Partners Management LP	6,011,100	$7.15M	0.3%	-1.1%	8.270%
11/14/2023	Pale Fire Capital SE	68,851	$82K	0.0%	N/A	0.095%
11/13/2023	Acadian Asset Management LLC	831,693	$0.99M	0.0%	+179.2%	1.144%
11/9/2023	Deutsche Bank AG	46,039	$55K	0.0%	-86.0%	0.063%
11/8/2023	Charles Schwab Investment Management Inc.	345,440	$0.41M	0.0%	+85.9%	0.475%
10/13/2023	SG Americas Securities LLC	32,841	$39K	0.0%	N/A	0.045%
10/12/2023	RVW Wealth LLC	23,765	$28K	0.0%	N/A	0.033%
9/21/2023	Barclays PLC	14,225	$35K	0.0%	-98.3%	0.020%
8/21/2023	California State Teachers Retirement System	23,740	$58K	0.0%	-63.2%	0.033%
8/16/2023	Nuveen Asset Management LLC	315,146	$0.77M	0.0%	-42.8%	0.434%
8/15/2023	Alliancebernstein L.P.	91,068	$0.22M	0.0%	+34.7%	0.125%
8/15/2023	Public Employees Retirement System of Ohio	18,200	$45K	0.0%	N/A	0.025%
8/15/2023	Walleye Capital LLC	429,181	$1.05M	0.0%	+72.5%	0.590%
8/15/2023	XTX Topco Ltd	94,643	$0.23M	0.0%	N/A	0.130%
8/15/2023	Y Intercept Hong Kong Ltd	19,604	$48K	0.0%	-45.7%	0.027%
8/15/2023	Goldman Sachs Group Inc.	1,344,965	$3.30M	0.0%	+24.3%	1.850%
8/15/2023	Point72 Middle East FZE	37,523	$92K	0.0%	+54.5%	0.052%
8/15/2023	Sphera Funds Management LTD.	1,988,228	$4.87M	0.8%	+5.3%	2.735%
8/15/2023	Suvretta Capital Management LLC	7,167,591	$17.56M	0.9%	+4.1%	9.860%
8/14/2023	Tower Research Capital LLC TRC	26,981	$66K	0.0%	+44.2%	0.037%
8/14/2023	Schonfeld Strategic Advisors LLC	66,300	$0.16M	0.0%	+29.3%	0.091%
8/14/2023	State Street Corp	1,095,716	$2.69M	0.0%	-66.2%	1.507%
8/14/2023	Nuveen Asset Management LLC	315,146	$0.77M	0.0%	-42.8%	0.434%
8/14/2023	Prosight Management LP	4,651,920	$11.40M	3.5%	+36.8%	6.400%
8/14/2023	Granahan Investment Management LLC	1,899,019	$4.65M	0.1%	+69.4%	2.612%
8/14/2023	Prelude Capital Management LLC	36,200	$89K	0.0%	+121.7%	0.050%
8/11/2023	Renaissance Technologies LLC	655,982	$1.61M	0.0%	-5.7%	0.906%
8/11/2023	BlackRock Inc.	5,089,147	$12.47M	0.0%	+14.2%	7.028%
8/11/2023	State Board of Administration of Florida Retirement System	20,256	$50K	0.0%	+99.8%	0.028%
8/11/2023	The Manufacturers Life Insurance Company	32,558	$80K	0.0%	+57.8%	0.045%
8/11/2023	Franklin Resources Inc.	1,388,157	$3.40M	0.0%	+1.7%	1.917%
8/11/2023	Geode Capital Management LLC	1,236,758	$3.03M	0.0%	+19.5%	1.708%
8/11/2023	JPMorgan Chase & Co.	1,079,681	$2.65M	0.0%	-0.7%	1.491%
8/11/2023	Northern Trust Corp	558,178	$1.37M	0.0%	-41.5%	0.771%
8/10/2023	MetLife Investment Management LLC	34,156	$84K	0.0%	+89.1%	0.047%
8/10/2023	Russell Investments Group Ltd.	180,715	$0.44M	0.0%	-38.8%	0.250%
8/10/2023	Charles Schwab Investment Management Inc.	185,869	$0.46M	0.0%	+30.6%	0.257%
8/10/2023	Citigroup Inc.	22,485	$55K	0.0%	-88.8%	0.031%
8/9/2023	BNP Paribas Arbitrage SNC	17,291	$42K	0.0%	-83.1%	0.024%
8/7/2023	Principal Financial Group Inc.	26,635	$65K	0.0%	+57.8%	0.037%
8/7/2023	Acadian Asset Management LLC	297,933	$0.73M	0.0%	+1,952.4%	0.411%
8/4/2023	American International Group Inc.	34,350	$84K	0.0%	+35.2%	0.047%
8/3/2023	Barclays PLC	14,225	$35K	0.0%	-98.3%	0.020%
8/3/2023	Bank of New York Mellon Corp	259,443	$0.64M	0.0%	+44.0%	0.358%
6/1/2023	Prelude Capital Management LLC	16,330	$51K	0.0%	N/A	0.023%
5/18/2023	JPMorgan Chase & Co.	1,087,290	$3.40M	0.0%	+1.5%	1.502%
5/18/2023	New York State Common Retirement Fund	23,597	$74K	0.0%	-38.1%	0.033%
5/16/2023	Jane Street Group LLC	92,597	$0.29M	0.0%	+211.5%	0.128%
5/16/2023	Sphera Funds Management LTD.	1,888,228	$5.91M	1.0%	+44.7%	2.608%
5/16/2023	State Street Corp	3,239,433	$10.14M	0.0%	-23.8%	4.474%
5/16/2023	Squarepoint Ops LLC	295,381	$0.93M	0.0%	N/A	0.408%
5/16/2023	Geode Capital Management LLC	1,034,959	$3.24M	0.0%	+5.9%	1.429%
5/15/2023	Schonfeld Strategic Advisors LLC	51,273	$0.16M	0.0%	-42.3%	0.071%
5/15/2023	Cubist Systematic Strategies LLC	244,143	$0.76M	0.0%	+1,059.1%	0.337%
5/15/2023	Suvretta Capital Management LLC	6,887,591	$21.56M	0.9%	+96.5%	9.517%
5/15/2023	Two Sigma Securities LLC	14,348	$45K	0.0%	N/A	0.020%
5/15/2023	Two Sigma Advisers LP	525,600	$1.65M	0.0%	+38.4%	0.726%
5/15/2023	Two Sigma Investments LP	571,378	$1.79M	0.0%	+1,976.8%	0.789%
5/15/2023	Deutsche Bank AG	322,583	$1.01M	0.0%	+4.8%	0.446%
5/15/2023	Moore Capital Management LP	85,000	$0.27M	0.0%	-32.0%	0.117%
5/15/2023	Boothbay Fund Management LLC	123,089	$0.39M	0.0%	+54.3%	0.170%
5/15/2023	Hood River Capital Management LLC	1,430,654	$4.48M	0.1%	+2.7%	1.977%
5/15/2023	Granahan Investment Management LLC	1,121,336	$3.51M	0.1%	+62.4%	1.549%
5/15/2023	Ghost Tree Capital LLC	175,000	$0.55M	0.2%	-48.5%	0.242%
5/12/2023	Renaissance Technologies LLC	695,684	$2.18M	0.0%	+737.2%	0.961%
5/12/2023	BlackRock Inc.	4,457,990	$13.95M	0.0%	+5.4%	6.160%
5/12/2023	BNP Paribas Arbitrage SNC	102,553	$0.32M	0.0%	+43.7%	0.142%
5/12/2023	Bank of America Corp DE	317,750	$1M	0.0%	-8.0%	0.439%
5/12/2023	Prudential Financial Inc.	80,330	$0.25M	0.0%	N/A	0.111%
5/12/2023	HRT Financial LP	25,947	$81K	0.0%	N/A	0.036%
5/12/2023	UBS Group AG	97,299	$0.31M	0.0%	-57.0%	0.134%
5/12/2023	Sei Investments Co.	28,941	$91K	0.0%	-16.4%	0.040%
5/12/2023	Martingale Asset Management L P	22,220	$70K	0.0%	-60.3%	0.031%
5/12/2023	Dimensional Fund Advisors LP	83,762	$0.26M	0.0%	-81.1%	0.116%
5/12/2023	Profund Advisors LLC	46,321	$0.15M	0.0%	N/A	0.064%
5/11/2023	Acadian Asset Management LLC	14,516	$45K	0.0%	N/A	0.020%
5/11/2023	CHI Advisors LLC	689,451	$2.16M	0.6%	-63.5%	0.953%
5/11/2023	FMR LLC	40,803	$0.13M	0.0%	-52.3%	0.056%
5/11/2023	Citigroup Inc.	200,190	$0.63M	0.0%	+30.5%	0.277%
5/11/2023	E Fund Management Co. Ltd.	14,149	$44K	0.0%	-22.6%	0.020%
5/10/2023	Credit Suisse AG	43,190	$0.14M	0.0%	+32.0%	0.060%
5/10/2023	Swiss National Bank	110,700	$0.35M	0.0%	-10.7%	0.153%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	88,899	$0.28M	0.0%	-55.9%	0.123%

Data available starting January 2016

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.79

$0.78

$0.82

50 Day Range

MA: $0.89

$0.78

$1.05

52 Week Range

Now: $0.79

$0.67

$3.13

Volume

539,990 shs

Average Volume

703,577 shs

Market Capitalization

$57.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Kezar Life Sciences?: Kezar Life Sciences' top insider shareholders include:
Morningside Venture Investment (Major Shareholder)
Learn More about top insider investors at Kezar Life Sciences.